Insider Purchase by Vivo Opportunity, LLC (10% Owner)
Trade Summary
3 days ago, Vivo Opportunity, LLC, serving as 10% owner Owner at InMed Pharmaceuticals Inc. (INM), purchased 20,546 shares at $1.55 per share, for a total transaction value of $31,846.30. Following this transaction, Vivo Opportunity, LLC now holds 75,019 shares of INM.
This purchase represents a 37.72% increase in Vivo Opportunity, LLC's stake in the company. This is considered a high-conviction trade given the significant change in ownership.
The trade was executed on Tuesday, July 14, 2026 and publicly disclosed via SEC Form 4 filing on Friday, July 17, 2026 (accepted Jul 16, 9:58 PM ET), 3 days after the trade was made.
InMed Pharmaceuticals Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.
Trade Price
$1.55
Quantity
20,546
Total Value
$31,846.30
Shares Owned
75,019
Trade Date
3 days ago
SEC Filing Date
(accepted Jul 16, 9:58 PM ET)
Filed 3 days after trade
Discussion